Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.72 (Miss by $-0.47) |
EPS GAAP Actual | $0.72 (Miss by $-0.47) |
Revenue Actual | $0.908B |
Revenue Surprise | Beat by $908M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.29 |
EPS GAAP Estimate | $1.29 |
Revenue Estimate | $1.409B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 7.88 | 4.41 | 7.52113 | 8.23887 | 1 |
Dec 2026 | 6.07 | 5.73 | 6.01484 | 6.12516 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.2 | -1.435 | 0.908B | 100% | -468M |
FQ4 2024 (Dec 2024) | 2.58 | 1.465 | 1.47B | 100% | 85.5M |
FQ3 2024 (Sep 2024) | -0.0806 | -1.1406 | 1.361B | 100% | 121.5M |
FQ1 2016 (Mar 2016) | -0.01 | -0.01 | 0B | NAN% | 0M |
FQ2 2016 (Jun 2016) | -0.0335 | -0.0335 | 2.4685E-5B | 100% | 0.02M |
FQ3 2016 (Sep 2016) | 0.0016 | 0.0016 | 0.000427153B | 100% | 0.43M |
FQ4 2016 (Dec 2016) | 0.0091 | 0.0091 | 0.000612594B | 100% | 0.61M |
FQ1 2017 (Mar 2017) | 0.38 | 0.38 | 0.375B | 100% | 375M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.29
Consensus Revenue Estimates
1.409B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 1.65 | -- | 1.59996 | 1.70004 | 1 |
FQ3 2026 (Sep 2026) | 1.57 | -- | 1.52239 | 1.61761 | 1 |
FQ2 2026 (Jun 2026) | 1.48 | -- | 1.43512 | 1.52488 | 1 |
FQ1 2026 (Mar 2026) | 1.4 | 114.29 | 1.35754 | 1.44246 | 1 |
FQ4 2025 (Oct 2025) | 1.33 | -93.98 | 1.29417 | 1.36583 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 1.47B | -- | 1.43B | 1.5B | 1 |
FQ3 2026 (Sep 2026) | 1.43B | -- | 1.39B | 1.46B | 1 |
FQ2 2026 (Jun 2026) | 1.39B | -- | 1.35B | 1.42B | 1 |
FQ1 2026 (Mar 2026) | 1.35B | 32.64 | 1.32B | 1.38B | 1 |
FQ4 2025 (Oct 2025) | 1.45B | -1.66 | 1.42B | 1.48B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.235 | -0.2 | -1.435 | 717.5% |
FQ4 2024 (Dec 2024) | 1.115 | 2.58 | 1.465 | 56.78% |
FQ3 2024 (Sep 2024) | 1.06 | -0.0806 | -1.1406 | 1415.14% |
FQ1 2016 (Mar 2016) | -0.01 | -0.01 | 100% | |
FQ2 2016 (Jun 2016) | -0.0335 | -0.0335 | 100% | |
FQ3 2016 (Sep 2016) | 0.0016 | 0.0016 | 100% | |
FQ4 2016 (Dec 2016) | 0.0091 | 0.0091 | 100% | |
FQ1 2017 (Mar 2017) | 0.38 | 0.38 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.38B | $0.91B | $-468M | -51.54% |
FQ4 2024 (Dec 2024) | $1.38B | $1.47B | $85.5M | 5.82% |
FQ3 2024 (Sep 2024) | $1.24B | $1.36B | $121.5M | 8.93% |
FQ1 2016 (Mar 2016) | $0B | $0B | $0M | NAN% |
FQ2 2016 (Jun 2016) | $0B | $0B | $0.02M | 100% |
FQ3 2016 (Sep 2016) | $0B | $0B | $0.43M | 100% |
FQ4 2016 (Dec 2016) | $0B | $0B | $0.61M | 100% |
FQ1 2017 (Mar 2017) | $0B | $0.38B | $375M | 100% |